RDDT delivered one of its sharpest weekly moves of the year, gaining 16% to close at $171.63 — and the story behind that move is a short base that sprinted in the wrong direction.
The numbers tell a clean story of trapped bears. Short interest has climbed 8% over the past week to 12.7% of the free float, even as the stock ripped higher. That's a rebuilding position walking straight into a earnings-driven surge — the April 30 Q1 print produced a 12.7% one-day jump, and shorts who added into that event are nursing losses. What makes this particularly notable is the longer-term context: short interest had been declining through most of April, falling from a peak near 19 million shares in late March to just above 16 million by mid-month. The post-earnings bounce reversed that trend sharply. Despite the fresh accumulation, borrow conditions remain loose — cost to borrow is just 0.40%, down roughly 10% over the past month, and availability is well above distressed levels. There is no mechanical squeeze pressure in the lending market at this point. The lend is cheap, supply is ample, and the short score of 54.5 has been drifting higher this week but sits far from extreme territory.
Options positioning adds a sharply bullish tilt to the picture. The put/call ratio dropped to 0.76 on Tuesday — nearly three standard deviations below its 20-day average of 0.83 — marking the most call-dominated reading of the past year. The 52-week low for the PCR is 0.57, so there is room to run further in that direction, but the current reading is already a meaningful outlier. Options traders are not hedging into the next event; they are leaning into the rally.
The Street updated targets almost universally after the Q1 beat. Evercore ISI lifted its target to $300 and Needham held at $300. Piper Sandler moved to $215. Cantor and Goldman both sit at $180, with Goldman maintaining Neutral — a notable holdout from the broader bullish consensus of 14 buys and 6 outperforms. Wells Fargo raised to $176 while holding Equal-Weight, essentially conceding that the stock has already reached fair value by its own model. The mean target of $223.63 represents roughly 30% upside from current levels, though Goldman and Wells Fargo sitting near the current price will anchor any consensus re-rating conversation. The PE of 22.5x has expanded roughly 3 points over the past month, tracking the stock's move; EV/EBITDA at 19.3x has compressed slightly, suggesting earnings upgrades are outpacing the price move on that metric.
Insider activity last month was one-directional. COO Jennifer Wong sold roughly $6.4m in aggregate across multiple tranches on April 16, and CEO Steve Huffman sold a further $2.8m on April 15. These were spread across many small transactions, consistent with a pre-arranged trading plan rather than discretionary exits, and the trade significance scores are low at 2/10. Still, the 90-day net insider figure shows $14.9m in net sales — a meaningful one-way flow. The institutional picture is more constructive. Vanguard added 1.1 million shares last quarter, JPMorgan added 461k, and T. Rowe Price added 233k. Tiger Global trimmed 828k, the largest reduction among named holders, but passive accumulation from the index complex is offsetting the active outflows.
The next print is scheduled for June 8. Between now and then, the question for RDDT is whether the current short interest — which just jumped 8% in a single week into the teeth of a rally — continues rebuilding at these higher prices, or whether the Q1 beat prompts another round of covering. The RSI at 62.8 is firm but not overbought. With cost to borrow barely above zero and plenty of borrow available, new shorts face no mechanical friction — only the momentum.
See the live data behind this article on ORTEX.
Open RDDT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
